William Fearon

William Fearon, MD is a Professor of Medicine (Cardiovascular Medicine) and Chief of the Interventional Cardiology Section at Stanford University School of Medicine, as well as Chief of Cardiology at the VA Palo Alto Health Care System. He graduated from Dartmouth College and earned his MD from Columbia University. His research focuses on coronary physiology, including the FAME trials and development of the Index of Microcirculatory Resistance (IMR). He leads major clinical trials in interventional cardiology and heart transplantation, with over 350 publications. Awards include Fellowship in the American College of Cardiology and election to the American Society for Clinical Investigation.

Education:

• B.A. in English, Dartmouth College (1990)
• M.D., Columbia University College of Physicians and Surgeons (1994)
• Residency: Stanford University Internal Medicine (1995-1998)
• Fellowships: Stanford General Cardiology & Interventional Cardiology (2002)

Research Interests: Coronary physiology, FFR-guided interventions, cardiac allograft vasculopathy, transcatheter valve therapy. Current NIH funding supports studies on post-transplant vasculopathy. Active in editorial roles for Circulation: Cardiovascular Interventions and JACC journals.

Key Trials:

• FAME 3 (5-year outcomes of PCI vs CABG)
• Contrast FFR validation (not recruiting)
• PASCAL valve repair trial (recruiting)

Awards: Over 30 teaching awards from Stanford, named Master Fellow by Society of Cardiovascular Angiography.

Labs: Leads a translational research lab investigating microvascular dysfunction and novel interventional therapies.